Cargando…

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion

Lymphocytic pleurisy is commonly observed in tuberculosis and cancer. Noninvasive biomarkers are needed to distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE) because current clinical diagnostic procedures are often invasive. We identified immune response biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kuan-Yuan, Feng, Po-Hao, Chang, Chih-Cheng, Chen, Tzu-Tao, Chuang, Hsiao-Chi, Lee, Chun-Nin, Su, Chien-Ling, Lin, Lian-Yu, Lee, Kang-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910680/ https://www.ncbi.nlm.nih.gov/pubmed/27354819 http://dx.doi.org/10.2147/IJGM.S100237

Ejemplares similares

Tuberculous Pleural Effusion
por: Schlesinger, Shira A., et al.
Publicado: (2012)

Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods
por: Darooei, Reza, et al.
Publicado: (2017)

Alterations by Air Pollution in Inflammation and Metals in Pleural Effusion of Pneumonia Patients
por: Bai, Kuan-Jen, et al.
Publicado: (2019)

Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022)

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions
por: Wang, Maoshui, et al.
Publicado: (2014)

Malignant and Tuberculous Pleural Effusions: Immunophenotypic Cellular Characterization
por: de Aguiar, Lucia Maria Zanatta, et al.
Publicado: (2008)

Sputum AFB in tuberculous pleural effusion
por: Wiwanitkit, Viroj
Publicado: (2011)

Factors Influencing Residual Pleural Opacity in Tuberculous Pleural Effusion
por: Kwon, Jee-Sook, et al.
Publicado: (2008)

Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
por: Al-aarag, Abdel-sadek Hamed, et al.
Publicado: (2019)

VEGF Correlates with Inflammation and Fibrosis in Tuberculous Pleural Effusion
por: Bien, Mauo-Ying, et al.
Publicado: (2015)

Vascular endothelial growth factor in malignant and tuberculous pleural effusions.
por: Lim, S. C., et al.
Publicado: (2000)

Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study
por: Fei, Guo, et al.
Publicado: (2023)

Role of therapeutic thoracentesis in tuberculous pleural effusion
por: Bhuniya, Sourin, et al.
Publicado: (2012)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

High IL-35 Pleural Expression in Patients with Tuberculous Pleural Effusion
por: Dong, Xuan, et al.
Publicado: (2015)

Tuberculous pleural effusion occurring concurrently with asbestos-related pleural disease
por: Zantah, Massa, et al.
Publicado: (2017)

GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
por: Liu, Yongxia, et al.
Publicado: (2021)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Development and validation of a prediction model to assess the probability of tuberculous pleural effusion in patients with unexplained pleural effusion
por: Lei, Xiaoli, et al.
Publicado: (2023)

Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion
por: Chen, Wei-Lin, et al.
Publicado: (2023)

Endothelin-1 Induces Mesothelial Mesenchymal Transition and Correlates with Pleural Fibrosis in Tuberculous Pleural Effusions
por: Wu, Zhung-Han, et al.
Publicado: (2019)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Dalil Roofchayee, Neda, et al.
Publicado: (2021)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions
por: Hsieh, Wen-Yeh, et al.
Publicado: (2012)

Polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion
por: Okauchi, Shinichiro, et al.
Publicado: (2020)

A scoring model for diagnosis of tuberculous pleural effusion
por: Wu, Senquan, et al.
Publicado: (2022)

Pleural Effusion
por: Gray, Frank D.
Publicado: (1963)

Pleural Effusion
por: Brunton, T. Lauder
Publicado: (1898)

Pleural Effusion
por: Sherding, Robert G., et al.
Publicado: (2006)

Pleural Effusions
Publicado: (1877)

Analysis of Cytokine Levers in Pleural Effusions of Tuberculous Pleurisy and Tuberculous Empyema
por: Yang, Lei, et al.
Publicado: (2016)

Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion
por: Cheng, Yi-Jing, et al.
Publicado: (2020)

T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions
por: Roofchayee, Neda Dalil, et al.
Publicado: (2021)

IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions
por: XUAN, WEI-XIA, et al.
Publicado: (2014)

MicroRNAs – novel biomarkers for malignant pleural effusions
por: Wojczakowski, Wiktor, et al.
Publicado: (2019)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tr0kpb3nt5m2bg8o35539klfse